Insiders Psychemedics Corporation

Equities

PMD

US7443752057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
2.43 ^USD	+4.29%		+0.41%	-17.91%

Jun. 21	Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing	CI
Mar. 28	Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer	23-09-21	CI
Psychemedics Names Chief Revenue Officer	23-09-21	MT
Psychemedics Corporation Announces Charles Doucot, to Leave as Executive Vice President, Effective September 15, 2023	23-08-31	CI
Psychemedics Corporation Announces Board Changes	23-07-14	CI
Psychemedics Corporation Announces CEO Changes	23-07-14	CI
Psychemedics Says Brian Hullinger to Succeed Ray Kubacki as CEO, Effective Aug. 17	23-07-12	MT
Psychemedics Corporation Appoints William Norris as Controller of the Company, Effective as of January 1, 2023	22-12-30	CI
Psychemedics Corporation Announces Executive Changes	22-08-17	CI
Psychemedics Corporation Announces Retirement of Walter S. Tomenson, Jr. from Board	22-06-09	CI
Peter H. Kamin Engages in Discussions with Psychemedics Corporation	22-05-10	CI
Psychemedics Corporation Announces Board Changes	22-03-22	CI
Psychemedics Corporation Announces Board Changes	22-03-22	CI
Psychemedics Corporation Elects Robyn C. Davis on the Board of Director, Effective Immediately	21-03-17	CI
Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller	21-01-26	CI
Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel	20-12-17	CI
Psychemedics Corporation Announces Resignation of Neil L. Lerner as Its Vice President-Finance, Treasurer and Assistant Secretary of the Corporation, Effective November 27, 2020	20-11-16	CI
Psychemedics Corporation Promotes James Abely as Vice President and General Counsel	18-05-08	CI
Psychemedics Corporation Appoints Charles M. Doucot as Vice President, Sales and Marketing	18-05-02	CI
James V. Dyke Resigns as Corporate Vice President of Sales and Marketing of Psychemedics Corporation	17-07-13	CI
Psychemedics Corporation Appoints James P. Abely as Associate General Counsel	16-06-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Psychemedics Corporation

Equities

PMD

US7443752057

Insiders

Filters